ArriVent BioPharma, Inc. Income Statement
Last quarter (Q2 2024), ArriVent BioPharma, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q2, ArriVent BioPharma, Inc.'s net income was $-21.87M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.